Director & Chief Executive Officer
Director & Chief Executive Officer at Rapport Therapeutics, Inc., filing insider transactions between 2025-09-04 and 2026-02-18. Also reports transactions at 1 other company.
| SEC ↗ |
| 2026-02-18 | RAPP | Sale | 3,552 | $29.05 | $103K | SEC ↗ |
| 2026-01-20 | RAPP | Sale | 5,833 | $26.12 | $152K | SEC ↗ |
| 2026-01-20 | RAPP | Sale | 5,083 | $26.11 | $133K | SEC ↗ |
| 2025-12-17 | RAPP | Sale | 515 | $31.04 | $16K | SEC ↗ |
| 2025-12-17 | RAPP | Sale | 600 | $31.04 | $19K | SEC ↗ |
| 2025-12-17 | RAPP | Sale | 2,147 | $28.84 | $62K | SEC ↗ |
| 2025-12-17 | RAPP | Sale | 2,421 | $30.04 | $73K | SEC ↗ |
| 2025-12-17 | RAPP | Sale | 2,441 | $28.84 | $70K | SEC ↗ |
| 2025-12-17 | RAPP | Sale | 2,792 | $30.04 | $84K | SEC ↗ |
| 2025-11-17 | RAPP | Sale | 2,242 | $24.91 | $56K | SEC ↗ |
| 2025-11-17 | RAPP | Sale | 2,777 | $24.92 | $69K | SEC ↗ |
| 2025-11-17 | RAPP | Sale | 2,841 | $25.44 | $72K | SEC ↗ |
| 2025-11-17 | RAPP | Sale | 3,056 | $25.43 | $78K | SEC ↗ |
| 2025-10-15 | RAPP | Sale | 4,328 | $25.75 | $111K | SEC ↗ |
| 2025-10-15 | RAPP | Sale | 755 | $26.17 | $20K | SEC ↗ |
| 2025-10-15 | RAPP | Sale | 1,186 | $26.14 | $31K | SEC ↗ |
| 2025-10-15 | RAPP | Sale | 4,647 | $25.72 | $120K | SEC ↗ |
| 2025-09-17 | RAPP | Sale | 1,400 | $26.87 | $38K | SEC ↗ |
| 2025-09-17 | RAPP | Sale | 34.9K | $26.30 | $918K | SEC ↗ |
| 2025-09-17 | RAPP | Sale | 39.4K | $26.30 | $1.0M | SEC ↗ |
| 2025-09-17 | RAPP | Sale | 700 | $27.04 | $19K | SEC ↗ |
| 2025-09-04 | PCRX | Sale | 2,354 | $27.19 | $64K | SEC ↗ |